Checkpoint Trends Stock Hits All-Time High at Rs.111.75

7 hours ago
share
Share Via
Checkpoint Trends, a key player in the Pharmaceuticals & Biotechnology sector, reached a new all-time high of Rs.111.75 today, marking a significant milestone in its market journey. The stock’s sustained upward momentum reflects a remarkable performance over multiple time frames, outpacing broader market indices and sector peers.



Strong Momentum Drives Record High


On 8 December 2025, Checkpoint Trends opened at Rs.111.75, maintaining this level throughout the trading session and touching an intraday peak at the same price. The stock recorded a day gain of 2.00%, outperforming the Sensex, which declined by 0.33% on the same day. This price action underscores the stock’s robust demand and investor confidence within the Pharmaceuticals & Biotechnology sector.


The stock has been on a consistent upward trajectory, registering gains for 21 consecutive trading days. Over this period, Checkpoint Trends delivered a cumulative return of 51.36%, a performance that significantly surpasses the sector average and broader market benchmarks. The stock’s ability to sustain such gains over three weeks highlights the strength of its underlying fundamentals and market positioning.



Outperformance Across Multiple Time Horizons


Checkpoint Trends’ performance over various time frames illustrates its exceptional growth relative to the Sensex. Over the past week, the stock appreciated by 10.38%, while the Sensex recorded a marginal decline of 0.24%. The one-month return stands at 51.36%, compared to the Sensex’s 2.66%, demonstrating the stock’s capacity to generate substantial value in a relatively short period.


Longer-term metrics further accentuate this trend. Over three months, Checkpoint Trends surged by 189.36%, vastly outpacing the Sensex’s 5.75% gain. The one-year performance is particularly striking, with the stock registering a 597.13% increase, while the Sensex rose by 4.56%. Year-to-date figures reveal an even more pronounced divergence, with Checkpoint Trends advancing 756.32% against the Sensex’s 9.33%.




Turnaround taking shape! This Small Cap from NBFC sector just hit profitability with strong business fundamentals showing up. Catch it before the major breakout happens!



  • - Recently turned profitable

  • - Strong business fundamentals

  • - Pre-breakout opportunity


Catch the Breakout Early →




Long-Term Growth Trajectory


Checkpoint Trends’ growth over extended periods further cements its status as a high-performing stock within its sector. Over three years, the stock appreciated by 2599.28%, a figure that dwarfs the Sensex’s 36.54% gain during the same period. The five-year return of 4479.92% similarly eclipses the Sensex’s 87.32%, highlighting the company’s sustained ability to generate shareholder value over the medium term.


Over a decade, Checkpoint Trends’ stock price has expanded by an extraordinary 7606.90%, compared to the Sensex’s 237.54%. This long-term performance reflects the company’s consistent execution and resilience in the Pharmaceuticals & Biotechnology sector, which has been characterised by innovation and evolving market dynamics.



Technical Indicators Support Uptrend


From a technical perspective, Checkpoint Trends is trading above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment of short-, medium-, and long-term moving averages signals a strong upward trend and suggests that the stock’s current price level is supported by sustained buying interest.


The stock’s opening gap of 2% today further emphasises the positive momentum, indicating that market participants are willing to transact at higher prices from the outset of trading. This behaviour often reflects confidence in the company’s recent performance and market positioning.




Considering Checkpoint Trends ? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this micro-cap with top-rated alternatives now!



  • - Better options discovered

  • - Pharmaceuticals & Biotechnology + beyond scope

  • - Top-rated alternatives ready


Compare & Switch Now →




Sector and Market Context


Checkpoint Trends operates within the Pharmaceuticals & Biotechnology sector, an industry known for its innovation-driven growth and critical role in healthcare. The company’s market capitalisation grade of 4 indicates a mid-sized presence within this competitive landscape. Its recent price performance has outpaced not only the sector averages but also the broader market indices, underscoring its distinctive market position.


The stock’s ability to maintain gains over multiple time frames, from daily to decade-long horizons, reflects a combination of strategic execution and favourable market conditions. While the broader Sensex has shown moderate growth, Checkpoint Trends’ returns have been markedly higher, illustrating its unique trajectory within the Indian equity market.



Summary of Key Price Movements


Checkpoint Trends’ stock price today reached Rs.111.75, setting a new 52-week and all-time high. The stock’s day change of 2.00% contrasts with the Sensex’s decline of 0.33%, highlighting relative strength. Over the last 21 trading sessions, the stock has delivered a total return of 51.36%, a period during which it has consistently recorded gains.


Performance comparisons with the Sensex reveal Checkpoint Trends’ exceptional returns across all measured intervals, including one week (10.38% vs -0.24%), one month (51.36% vs 2.66%), three months (189.36% vs 5.75%), one year (597.13% vs 4.56%), year-to-date (756.32% vs 9.33%), three years (2599.28% vs 36.54%), five years (4479.92% vs 87.32%), and ten years (7606.90% vs 237.54%).



Conclusion


Checkpoint Trends’ achievement of an all-time high at Rs.111.75 marks a significant milestone in its market history. The stock’s sustained gains over short, medium, and long-term periods, combined with its outperformance relative to the Sensex and sector benchmarks, reflect a strong market presence and consistent value creation. Trading above all major moving averages, the stock’s technical indicators align with its fundamental strength, underscoring the significance of this new peak in its price journey.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News